Element Biosciences vs Ray Therapeutics
Element Biosciences vs Ray Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Element Biosciences is on 53/100 and Ray Therapeutics on 53/100.
Where each one leads
Element Biosciences
- agent readiness: 34/100 against 21/100
- domain rating: 66/100 against 29/100
Ray Therapeutics
- funding raised: $243M against $175M
At a glance
| Measure | Element Biosciences | Ray Therapeutics |
|---|---|---|
| What it is | Revolutionizing genomic analysis with innovative sequencing technology. | Pioneering vision restoration therapies for severe retinal degenerations. |
| Category | Biotechnology, Genomics, Life Sciences, Healthcare Technology | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Services |
| Founded | 2017 | 2021 |
| Headquarters | San Diego, USA | Berkeley, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Element Biosciences | Ray Therapeutics |
|---|---|---|
| Total funding | $175M | $243M |
| Latest round | Series E | Series B |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Element Biosciences | Ray Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 53/100 |
| Traction | 40/100 | 40/100 |
| Team | Not published | 50/100 |
| Search visibility | 2/100 | 14/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (34/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 66/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Element Biosciences | Ray Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Analytics 4, Google Tag Manager | Google Analytics 4 |
| Support stack | HubSpot | Not detected |
What users say
| Measure | Element Biosciences | Ray Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | 1 positive, 0 negative across 3 threads | Not published |
“The cost of sequencing human genome has fallen from $100M to under $100 in approximately 25 years. Element Biosciences reportedly hit the $100 genome milestone (Feb 2026).”r/singularity
Element Biosciences vs Ray Therapeutics: common questions
Which is better, Element Biosciences or Ray Therapeutics?
Both score the same on our 0-100 rating, so the choice comes down to the 18 data points in the tables above rather than overall company strength.
How do Element Biosciences and Ray Therapeutics compare on the numbers?
Element Biosciences leads on agent readiness (34/100 against 21/100), domain rating (66/100 against 29/100). Ray Therapeutics leads on funding raised ($243M against $175M).
What do real users say about Element Biosciences and Ray Therapeutics?
Element Biosciences: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/singularity.
Read the full Element Biosciences review and pricing or the Ray Therapeutics review and pricing. You can also browse other Element Biosciences alternatives we track.